National Institutes of Health Grants

National Institutes of Health · Up to $250K

This NIH/NLM R01 grant funds research teams developing and evaluating clinical informatics tools and methods that turn health data (such as electronic health records, clinical notes, and imaging) into actionable knowledge. Both U.S. and foreign organizations are eligible to apply, but applications involving funded foreign subawards/subcontracts will be rejected under NIH's post-May-2025 policy. The award ceiling is up to about $250,000.

National Institutes of Health · Up to $250K

This NIH/NLM R01 grant supports research advancing bioinformatics, translational bioinformatics, and computational biology, including AI and machine-learning methods for interpreting large biological datasets. Both U.S. and foreign organizations may apply, but applications that include funded foreign subawards/subcontracts will be deemed noncompliant and not considered. The award ceiling is up to about $250,000.

National Institutes of Health · Amount varies

This NIH (K12) career development award supports institutions in training clinician-scientists for clinical and translational cancer research. It is an institutional mentored program; scholars may gain experience in a mentor-led clinical trial but may not lead an independent clinical trial. Only domestic U.S. organizations may apply, foreign organizations are not eligible, though foreign components are allowed. It primarily suits academic medical centers and research institutions building oncology research careers.

National Institutes of Health · Amount varies

This NIH (R03) award helps investigators enter high-priority substance use research, including HIV comorbidity, by funding the collection of preliminary data to support future larger grants and career advancement. Eligibility is comparatively open for NIH: foreign organizations and foreign components of U.S. organizations are both eligible to apply, and foreign components are allowed. It suits researchers and institutions transitioning into substance use research fields. No specific award amount is listed.

National Institutes of Health · Amount varies

This NIH SBIR Phase IIB award is restricted to U.S. small business concerns that have previously received an NIH SBIR or STTR Phase II award; it bridges the gap between Phase II and commercialization for later-stage R&D. Only one such award is allowed per project, and applications must be submitted within the first six due dates after the Phase II budget period ends, so it is narrow and limited to existing grantees. Foreign organizations are not eligible to apply.

National Institutes of Health · Amount varies

This NIH SBIR/STTR Commercialization Readiness Pilot (CRP) is restricted to U.S. small business concerns (as defined by the SBA) and helps move NIH-funded SBIR/STTR projects from late-stage development toward commercialization. It supports later-stage R&D and technical assistance such as replication studies, IND/IDE-enabling work, clinical studies, manufacturing scale-up, and regulatory support, and a significant portion may be subcontracted. Foreign organizations are not eligible to apply.

National Institutes of Health · Amount varies

This NIH Predoctoral-to-Postdoctoral Transition Award (F99/K00) supports promising graduate students as they finish doctoral research and move into mentored postdoctoral career development, in NIH mission-relevant fields. It is a mentored training award administered through institutions; candidates may not lead an independent clinical trial but may participate in a sponsor-led one. Only domestic U.S. organizations may apply; foreign organizations are not eligible, though foreign components are allowed.

National Institutes of Health · Amount varies

This NIH Research Education Program (R25/UE5) funds mentoring activities and networks that develop the biomedical, behavioral, and clinical research workforce. It requires institutional commitment of staff, facilities, and resources, and proposed activities must be distinct from any existing federally funded training programs (such as T32) at the applicant. Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted.

National Institutes of Health · Amount varies

This NIH Research Education Program (R25) funds hands-on research experiences that help build and diversify the biomedical, behavioral, and clinical research workforce. It is aimed at institutions that can provide the staff, facilities, and educational resources to run such programs, and proposed activities must be distinct from any existing federally funded training grants (such as T32). Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted.

National Institutes of Health · Amount varies

This NIH parent opportunity supports research projects built around international collaborations between a U.S. (domestic prime) organization and foreign partners, and at least one international subproject is required. Only domestic U.S. organizations may apply as the prime; non-U.S. entities cannot apply directly, though funded foreign components are allowed. It is aimed at research institutions and universities pursuing health-related projects that need talent, populations, or resources found in other countries. Applicants should expect to manage a linked prime-and-foreign-subaward structure.

National Institutes of Health · Amount varies

This NIH (X01) opportunity does not provide cash funding but instead grants investigators access to services from a state-of-the-art Biological Testing Facility to advance contraceptive development or reproductive health research. Applicants do not need current NIH funding, though priority may go to programs already receiving NIH support. Notably, foreign organizations are eligible to apply, but foreign components of U.S. organizations and foreign components in general are not allowed. It suits researchers needing specialized biological testing resources.

National Institutes of Health · Amount varies

This NIH/NIAID Program Project (P01) opportunity funds multi-component research programs in infectious disease and immunology, including HIV, immune dysfunction, allergy, autoimmunity, and vaccine/therapeutic/diagnostic development. Each application must include at least two related research projects plus an administrative core, so it is geared toward research institutions with established teams. Only domestic U.S. organizations may apply; foreign organizations are not eligible, though foreign components are allowed. Clinical trials are not permitted under this NOFO.

National Institutes of Health · Amount varies

This NIH Research Education Program (R25) funds the development of courses, curricula, and educational methods that strengthen the biomedical, behavioral, and clinical research workforce. It is aimed at institutions that can commit staff, facilities, and educational resources, and proposed activities must be distinct from any existing federally funded training grants (such as T32) at the applicant. Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted.

National Institutes of Health · Amount varies

This NIH/NIAID Resource-Related Research Project (R24) opportunity funds the creation or support of shared scientific resources that benefit high-priority research in infectious disease and immunology. NIAID expects to use it infrequently, only when other funding mechanisms are not appropriate, so it is a narrow opportunity for research institutions. Only domestic U.S. organizations may apply; foreign organizations are not eligible, though foreign components are allowed, and clinical trials are not permitted.

National Institutes of Health · Amount varies

This NIH award is open only to U.S. institutions located in IDeA-eligible states/jurisdictions (a fixed list including Alaska, Arkansas, Delaware, Hawaii, Kentucky, Mississippi and others) that grant doctoral degrees in health-related sciences or are NIH-funded biomedical research institutes. It funds the expansion and sustainability of existing Centers of Biomedical Research Excellence, building faculty, research projects, and core facilities. Eligibility is narrow: it is a limited competition by invitation, applicants may hold no more than three active COBRE awards, and foreign organizations and foreign components are not eligible.

National Institutes of Health · Amount varies

The NIH Science Education Partnership Award (SEPA, R25) funds educational projects that increase understanding of biomedical research among pre-college (pre-K through grade 12) students and encourage interest in STEM careers. It suits universities, research institutions, and education-focused organizations that can run science education programs. Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted.

National Institutes of Health · Amount varies

This NIH/NIAID (U01) cooperative agreement funds the implementation of investigator-initiated, milestone-driven clinical trials that need enhanced oversight, optionally including mechanistic studies, for up to 5 (or extended 6-7) years. A clinical trial is required and only one trial may be proposed per application, so it suits research institutions ready to run a defined trial in infectious disease or immunology. Eligibility is comparatively open for NIH: foreign organizations and foreign components of U.S. organizations are both eligible to apply, and foreign components are allowed.

National Institutes of Health · Up to $500K

This NIH (U01) cooperative agreement funds research into the human behaviors that affect oral and systemic health among people with chronic conditions, including projects that develop or test causal hypotheses, with a stated budget up to about $500,000. It is aimed at research institutions studying behavioral, biological, and psychosocial drivers of health outcomes. Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted under this NOFO.

National Institutes of Health · Amount varies

This NIH/NCI (U01) cooperative agreement funds research using cancer epidemiology cohort studies to address gaps in cancer causes and survivorship, including cohort infrastructure, continued follow-up, and data/biospecimen sharing. It is aimed at research institutions running or analyzing large epidemiologic cohorts. Eligibility is comparatively open for NIH: foreign organizations and foreign components of U.S. organizations are eligible to apply, though foreign components as defined by NIH are not allowed. Clinical trials are not permitted under this NOFO.

National Institutes of Health · Up to $500K

This NIH/NIDCR (U01) cooperative agreement funds investigator-initiated observational or biomarker validation studies that require prospective collection or continued analysis of data and biospecimens, with a stated budget up to about $500,000. It is aimed at research institutions in NIDCR (dental, oral, and craniofacial) mission areas. Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted under this NOFO.